Therapeutic effects of gyokuheifusan on NC/Nga mouse model of allergic dermatitis

Hiroko Nakatsukasa, Fumitoshi Tago, Takuya Okamoto, Mitsutoshi Tsukimoto, Shuji Kojima

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Gyokuheifusan (GHS) is a traditional Chinese medicine (TCM) formula used to treat various allergic diseases; however, there is little information about its clinical efficacy or mechanism of action. We previously showed that GHS down-regulates over-production of IgE and interleukin (IL)-4 in a mouse model of ovalbumin (OVA)-induced asthma, a major Th2-dominant disease. Here, we investigated the effect of GHS in an NC/Nga mouse model of atopic dermatitis (AD) induced by mite antigen. NC/Nga mice were immunized with an intradermal injection of mite antigen extract twice a week from 6 to 12 weeks of age. GHS (3.0 g/kg) was orally administered daily to the GHS-treated group for 6 weeks, and dermatitis score and total serum IgE level were measured sequentially. Spleen was harvested at 13 weeks of age, and the levels of cytokines released from splenocytes (interferon (IFN)-γ, IL-4 and IL-5) and IgG1/IgG2a levels in sera were measured by ELISA. Mice treated with GHS showed milder dermatitis than the disease-control group and the increase of total serum IgE level tended to be suppressed by GHS. In addition, GHS treatment suppressed the production of IL-4 and IgG1, though it did not affect the production of IFN-γ and IgG2a; i.e., GHS normalized the Th1/Th2 balance. These results suggest that GHS inhibits the development and reduces the severity of AD, at least in this model.

Original languageEnglish
Pages (from-to)516-524
Number of pages9
JournalJournal of Health Science
Volume55
Issue number4
DOIs
Publication statusPublished - 2009 Aug 1
Externally publishedYes

Fingerprint

Dermatitis
Therapeutic Uses
Interleukin-4
Immunoglobulin E
Interferons
Mites
Atopic Dermatitis
Immunoglobulin G
Disease control
Antigens
Serum
Interleukin-5
Ovalbumin
Th1-Th2 Balance
Intradermal Injections
Medicine
Chinese Traditional Medicine
Cytokines
Down-Regulation
Spleen

Keywords

  • Atopic dermatitis
  • Gyokuheifusan
  • Th1/Th2 balance

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Therapeutic effects of gyokuheifusan on NC/Nga mouse model of allergic dermatitis. / Nakatsukasa, Hiroko; Tago, Fumitoshi; Okamoto, Takuya; Tsukimoto, Mitsutoshi; Kojima, Shuji.

In: Journal of Health Science, Vol. 55, No. 4, 01.08.2009, p. 516-524.

Research output: Contribution to journalArticle

Nakatsukasa, Hiroko ; Tago, Fumitoshi ; Okamoto, Takuya ; Tsukimoto, Mitsutoshi ; Kojima, Shuji. / Therapeutic effects of gyokuheifusan on NC/Nga mouse model of allergic dermatitis. In: Journal of Health Science. 2009 ; Vol. 55, No. 4. pp. 516-524.
@article{afecb05e2e904fbebaefe96bd9e317b1,
title = "Therapeutic effects of gyokuheifusan on NC/Nga mouse model of allergic dermatitis",
abstract = "Gyokuheifusan (GHS) is a traditional Chinese medicine (TCM) formula used to treat various allergic diseases; however, there is little information about its clinical efficacy or mechanism of action. We previously showed that GHS down-regulates over-production of IgE and interleukin (IL)-4 in a mouse model of ovalbumin (OVA)-induced asthma, a major Th2-dominant disease. Here, we investigated the effect of GHS in an NC/Nga mouse model of atopic dermatitis (AD) induced by mite antigen. NC/Nga mice were immunized with an intradermal injection of mite antigen extract twice a week from 6 to 12 weeks of age. GHS (3.0 g/kg) was orally administered daily to the GHS-treated group for 6 weeks, and dermatitis score and total serum IgE level were measured sequentially. Spleen was harvested at 13 weeks of age, and the levels of cytokines released from splenocytes (interferon (IFN)-γ, IL-4 and IL-5) and IgG1/IgG2a levels in sera were measured by ELISA. Mice treated with GHS showed milder dermatitis than the disease-control group and the increase of total serum IgE level tended to be suppressed by GHS. In addition, GHS treatment suppressed the production of IL-4 and IgG1, though it did not affect the production of IFN-γ and IgG2a; i.e., GHS normalized the Th1/Th2 balance. These results suggest that GHS inhibits the development and reduces the severity of AD, at least in this model.",
keywords = "Atopic dermatitis, Gyokuheifusan, Th1/Th2 balance",
author = "Hiroko Nakatsukasa and Fumitoshi Tago and Takuya Okamoto and Mitsutoshi Tsukimoto and Shuji Kojima",
year = "2009",
month = "8",
day = "1",
doi = "10.1248/jhs.55.516",
language = "English",
volume = "55",
pages = "516--524",
journal = "Journal of Health Science",
issn = "1344-9702",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Therapeutic effects of gyokuheifusan on NC/Nga mouse model of allergic dermatitis

AU - Nakatsukasa, Hiroko

AU - Tago, Fumitoshi

AU - Okamoto, Takuya

AU - Tsukimoto, Mitsutoshi

AU - Kojima, Shuji

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Gyokuheifusan (GHS) is a traditional Chinese medicine (TCM) formula used to treat various allergic diseases; however, there is little information about its clinical efficacy or mechanism of action. We previously showed that GHS down-regulates over-production of IgE and interleukin (IL)-4 in a mouse model of ovalbumin (OVA)-induced asthma, a major Th2-dominant disease. Here, we investigated the effect of GHS in an NC/Nga mouse model of atopic dermatitis (AD) induced by mite antigen. NC/Nga mice were immunized with an intradermal injection of mite antigen extract twice a week from 6 to 12 weeks of age. GHS (3.0 g/kg) was orally administered daily to the GHS-treated group for 6 weeks, and dermatitis score and total serum IgE level were measured sequentially. Spleen was harvested at 13 weeks of age, and the levels of cytokines released from splenocytes (interferon (IFN)-γ, IL-4 and IL-5) and IgG1/IgG2a levels in sera were measured by ELISA. Mice treated with GHS showed milder dermatitis than the disease-control group and the increase of total serum IgE level tended to be suppressed by GHS. In addition, GHS treatment suppressed the production of IL-4 and IgG1, though it did not affect the production of IFN-γ and IgG2a; i.e., GHS normalized the Th1/Th2 balance. These results suggest that GHS inhibits the development and reduces the severity of AD, at least in this model.

AB - Gyokuheifusan (GHS) is a traditional Chinese medicine (TCM) formula used to treat various allergic diseases; however, there is little information about its clinical efficacy or mechanism of action. We previously showed that GHS down-regulates over-production of IgE and interleukin (IL)-4 in a mouse model of ovalbumin (OVA)-induced asthma, a major Th2-dominant disease. Here, we investigated the effect of GHS in an NC/Nga mouse model of atopic dermatitis (AD) induced by mite antigen. NC/Nga mice were immunized with an intradermal injection of mite antigen extract twice a week from 6 to 12 weeks of age. GHS (3.0 g/kg) was orally administered daily to the GHS-treated group for 6 weeks, and dermatitis score and total serum IgE level were measured sequentially. Spleen was harvested at 13 weeks of age, and the levels of cytokines released from splenocytes (interferon (IFN)-γ, IL-4 and IL-5) and IgG1/IgG2a levels in sera were measured by ELISA. Mice treated with GHS showed milder dermatitis than the disease-control group and the increase of total serum IgE level tended to be suppressed by GHS. In addition, GHS treatment suppressed the production of IL-4 and IgG1, though it did not affect the production of IFN-γ and IgG2a; i.e., GHS normalized the Th1/Th2 balance. These results suggest that GHS inhibits the development and reduces the severity of AD, at least in this model.

KW - Atopic dermatitis

KW - Gyokuheifusan

KW - Th1/Th2 balance

UR - http://www.scopus.com/inward/record.url?scp=68949117590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949117590&partnerID=8YFLogxK

U2 - 10.1248/jhs.55.516

DO - 10.1248/jhs.55.516

M3 - Article

AN - SCOPUS:68949117590

VL - 55

SP - 516

EP - 524

JO - Journal of Health Science

JF - Journal of Health Science

SN - 1344-9702

IS - 4

ER -